Request free EDS demo software at
EDS is exclusively distributed in Europe on Delica TCD systems
Shenzhen, China.
​
3 VALIDATED & PUBLISHED ALGORITHMS FOR DIFFERENT CLINICAL INDICATIONS
​
#1.SOLID & ARTEFACT (TIA&Stroke)
#2.GASEOUS & ARTEF (PFO&PVI)
#3.SOLID/GAS/ARTEF (CABG&TAVI)
​
USER FRIENDLY
MONITORING AND VERIFICATION GUI
ARTIFICIAL INTELLIGENCE ALLOWS
RAPID DIAGNOSIS OF
LONGTERM TCD TIMESERIES
ALLOWS EXPORT OF AUDIOFILES, MES & ARTEFACT VALUES FOR
ADVANCED STATISTICS
SCIENTIFICALLY BACKED UP
IN PEER-REVIEWED
PUBLICATIONS
EDS Mission
​
To spread the insight to the medical community that
the smart use of cerebral embolus detection software will prevent strokes in all patients with an increased stroke risk.
We will achieve this mission by:
1. Releasing free EDS demo's that teach you how solid en gaseous emboli look like under different clinical conditions.
​
2. Providing the medical community the best software to detect solid and gaseous emboli in TCD recordings.
​
3. Providing teaching files with different types of
solid & gaseous emboli and artifacts in the bloodstream.
4. Providing lectures on stroke prevention by TCD embolus detection.
​
5. Free review and feedback your own TCD audio-files.
​
​
Additional TCD Stroke Prevention Initiatives
developed by R.W.M. Keunen MD PhD
The Haga Braincare Strategy
The Haga Braincare Stragey has been developed to reduce the burden of focal and global ischemia related to cardiac surgery. It is a dual strategy in which patients with cerebral flow states are identified prior to surgery by TCD Ultrasound and in which patients are monitored per--operatively by non-invasive NIRS cerebral oximetry. In a retrospective follow-up study we noticed a the Haga Teaching Hospital an extinction of postoperative hemodynamic strokes and a > 50 % reduction of the post operative delirium...
Prevention of Malignant Cerebral Hyperfusion after Carotid Surgery or Angioplasthy
Cerebral hyperperfusion syndromes are reperfusion syndromes that may occur in the run off MCA territory after stenting or surgery of high grade ipsilateral carotid artery stenosis. Most of these hyperperfusion syndromes are transient phenomena with no residual brain lesions. However some of them result in a devastating hemorrhagic stroke. The main risk factors of such a devastating stroke is when systemic hypertension and failed cerebral auto regulation interact with each other. Implementing intelligent TCD and RR management in these patients may prevent such devastating strokes...
Current EDS research
Inspirators of the EDS development
Merrill Spencer Rune Aaslid Rob Ackerstaff Run
EDS Achievements
-
2007 Programmer Remco Hoogenboezem & vascular neurologist Ruud Keunen designed the first zero-crossing based embolus detection algorithm for discrimination for single solid emboli and artefacts from TCD audio recordings.
-
2008 EDS has been CE certified, published and brought to the European Market.
-
2009 Antonius Nieuwegein and University Medical Centre Utrecht amongst the first centres in Holland which started to monitor carotid surgery with EDS.
-
2015 Over 10 Dutch Vascular Medical Centres uses over 15 EDS systems mainly to monitor carotid surgery
-
2020 EDS is exclusively distributed on Delica TCD systems with a focus to serve European Medical Centres
-
2021 EDS was presented in over 20 lectures and zoom meetings over Europe
-
2022 Invited EDS lecture at University of Cambridge for Peter Smielewski and Marik Czosnyka
-
2022 Semmelweis University Budapest is the 10th European Medical Centre that uses the EDS software to monitor Pulmonary Vene Isolation
-
2022 EDS Medical and the Deventer hospital start a cooperation to validated the EDS PFO algorithm to detect gaseous emboli in TCD recordings.
-
2022 EDS presented a new Solild/Gaseous/Artefact Algorithm at the 22th ESNCH Meeting in Lisbon
-
2023 EDS lectures at the Karolinska University Stockholm and University of Orebro Sweden
-
2024 EDS published and validated a new PFO algorithm
EDS
The EDS is a premium CE certified software for detecting solid and gaseous emboli in the bloodstream. The EDS has been developed and validated by Dr. RWM Keunen, a Dutch neurologist working at the Haga Teaching Hosipitals, The Hague, The Netherlands.
Embolus detection is a unique diagnostic tool to identify patients with an increased stroke risk.
EDS is applied in the management of (a)symptomatic carotid artery stenosis, peri-operative monitoring of patients scheduled for carotid, cardiac, TAVI and PVI procedures
​
​
EDS Universities
Christian Doppler Uni, Salzburg, Austria
Karolinska Hospital, Stockholm, Sweden
Zurich University Hospital Switzerland
Semmelweis Budapest Hungary
Debrecen University Debrecen Hungary
Rostock University RostockGermany
Inselspital Bern Switzerland
Erasmus Rotterdam The Netherlands
UMCU Utrecht The Netherlands
UMC Groningen The Netherlands
UMC Maastricht The Netherlands
University of Kaunas Letland
Umea University Hospital Sweden
University of Wurzburg, Germany
​
​
EDS Hospitals
​
HagaZiekenhuis Den Haag, The Netherlands
Antonius Nieuwegein, The Netherlands
Elisabeth Tilburg, The Netherlands
Isala Klinieken, Zwolle. The Netherlands
Ziekenhuis Deventer, The Netherlands
Franciscus Rotterdam, The Netherlands
Catharina Eindhoven, The Netherlands
Dijklander Hoorn, The Netherlands
Marien Hospital Bottrop, Germany
Klinikum Esslingen, Germany
Klinikum Schaumburg, Germany
Kaposvár Hospital, Hungary
Lahn Dill Kliniken, Germany
​
EDS Delica Distributors
80 Beats Medical GmbH
Berlin Germany
for the DACH countries
www.80beatmedical.com
DHS Hungary Ltd.
Budapest Hungary
info@dhshungary.com
Disclosures Dr. Keunen
Dr. Keunen was vascular neurologist at the Haga Hospital from 1990-2020. Since 2021 Dr. Keunen is research neurologist at the department of cardiosurgery at the Haga Hospitals the Hague The Netherlands and owner of EDS Medical Softeware BV.
Dr. Keunen is medical advisor of Medtronic Trading NL BV The Netherlands. Delica China, SMT Medical Germany, Cardio Solutions The Netherlands and DHS Hungary.
